IDEAS home Printed from https://ideas.repec.org/e/pjo156.html
   My authors  Follow this author

Juergen John

(We have lost contact with this author. Please ask them to update the entry or send us the correct address or status for this person. Thank you.)

Personal Details

First Name:Juergen
Middle Name:
Last Name:John
Suffix:
RePEc Short-ID:pjo156
The above email address does not seem to be valid anymore. Please ask Juergen John to update the entry or send us the correct address or status for this person. Thank you.
http://www.helmholtz-muenchen.de

Affiliation

Institute für Gesundheitsökonomie und Management im Gesundheitswesen (IGM)
Helmholtz Zentrum für Gesundheit und Umwelt

München, Germany
http://www.helmholtz-muenchen.de/igm/
RePEc:edi:igmhzde (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Susanne Hartz & Jürgen John, 2007. "The contribution of economic evaluation to decision-making in early phases of product development: a methodological and empirical review," Jena Economics Research Papers 2007-094, Friedrich-Schiller-University Jena.
  2. Susanne Hartz & Jürgen John, 2007. "Public health policy decisions on medical innovations: What role can early economic evaluation play?," Jena Economics Research Papers 2007-095, Friedrich-Schiller-University Jena.

Articles

  1. Mareike Schad & Jürgen John, 2012. "Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(2), pages 127-144, April.
  2. Breitfelder, Ariane & Wenig, Christina M. & Wolfenstetter, Silke B. & Rzehak, Peter & Menn, Petra & John, Jürgen & Leidl, Reiner & Bauer, Carl Peter & Koletzko, Sibylle & Röder, Stefan & Herbarth, Olf, 2011. "Relative weight-related costs of healthcare use by children--Results from the two German birth cohorts, GINI-plus and LISA-plus," Economics & Human Biology, Elsevier, vol. 9(3), pages 302-315, July.
  3. Hartz, Susanne & John, Jürgen, 2009. "Public health policy decisions on medical innovations: What role can early economic evaluation play?," Health Policy, Elsevier, vol. 89(2), pages 184-192, February.
  4. Thomas Lengerke & Christian Janssen & Jürgen John, 2007. "Sense of coherence, health locus of control, and quality of life in obese adults: physical limitations and psychological normalcies," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 52(1), pages 16-26, February.
  5. Thomas Lengerke & Jürgen John, 2004. "On individualism, environmentalism, and the degree of complexity needed in obesity prevention: a response to Mokdad (2003)," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 49(1), pages 5-7, February.
  6. Winkelhake, Olaf & John, Jürgen, 2003. "Beiträge auf Vermögenseinkünfte: Zwischen Leistungsgerechtigkeit und Populismus," Wirtschaftsdienst – Zeitschrift für Wirtschaftspolitik (1949 - 2007), ZBW - Leibniz Information Centre for Economics, vol. 83(3), pages 188-191.
  7. Winkelhake Olaf & John Jürgen, 1999. "Umverteilungseffekte durch Reformen der Finanzierung der Gesetzlichen Krankenversicherung / Redistributional Effects of Health Care Financing Reforms in Germany," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 218(1-2), pages 197-214, February.
  8. Olaf Winkelhake & Jürgen John, 1998. "Risk equalization, competition and choice in Germany: A reply to Wysong and Abel," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 43(1), pages 3-4, January.
  9. Olaf Winkelhake & Andreas Mielck & Jürgen John, 1997. "Einkommen, Gesundheit und Inanspruchnahme des Gesundheitswesens in Deutschland 1992," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 42(1), pages 3-10, January.
  10. John, Jurgen & Potthoff, Peter, 1987. "Cost containment in a statutory health insurance scheme by substitution of outpatient for inpatient care? The case of the Bavarian Contract," Health Policy, Elsevier, vol. 8(2), pages 153-169, October.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Susanne Hartz & Jürgen John, 2007. "The contribution of economic evaluation to decision-making in early phases of product development: a methodological and empirical review," Jena Economics Research Papers 2007-094, Friedrich-Schiller-University Jena.

    Cited by:

    1. Maarten Ijzerman & Lotte Steuten, 2011. "Early assessment of medical technologies to inform product development and market access," Applied Health Economics and Health Policy, Springer, vol. 9(5), pages 331-347, September.
    2. Adam Fridhammar & Ulrika Axelsson & Ulf Persson & Anders Bjartell & Carl A. K. Borrebaeck, 2021. "The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of Development," PharmacoEconomics - Open, Springer, vol. 5(1), pages 77-88, March.
    3. Joyce Craig & Louise Carr & John Hutton & Julie Glanville & Cynthia Iglesias & Andrew Sims, 2015. "A Review of the Economic Tools for Assessing New Medical Devices," Applied Health Economics and Health Policy, Springer, vol. 13(1), pages 15-27, February.
    4. Petra Marešová & Lukáš Peter & Jan Honegr & Lukáš Režný & Marek Penhaker & Martin Augustýnek & Hana Mohelská & Blanka Klímová & Kamil Kuča, 2020. "Complexity Stage Model of the Medical Device Development Based on Economic Evaluation—MedDee," Sustainability, MDPI, vol. 12(5), pages 1-27, February.
    5. Markiewicz, Katarzyna & van Til, Janine A. & Steuten, Lotte M.G. & IJzerman, Maarten J., 2016. "Commercial viability of medical devices using Headroom and return on investment calculation," Technological Forecasting and Social Change, Elsevier, vol. 112(C), pages 338-346.
    6. Maarten J. IJzerman & Hendrik Koffijberg & Elisabeth Fenwick & Murray Krahn, 2017. "Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature," PharmacoEconomics, Springer, vol. 35(7), pages 727-740, July.

  2. Susanne Hartz & Jürgen John, 2007. "Public health policy decisions on medical innovations: What role can early economic evaluation play?," Jena Economics Research Papers 2007-095, Friedrich-Schiller-University Jena.

    Cited by:

    1. Maarten Ijzerman & Lotte Steuten, 2011. "Early assessment of medical technologies to inform product development and market access," Applied Health Economics and Health Policy, Springer, vol. 9(5), pages 331-347, September.
    2. Rozmarinová Jana & Říhová Barbora, 2021. "Health Technology Assessment of the Medical Devices: A Case Study from the Czech Republic," NISPAcee Journal of Public Administration and Policy, Sciendo, vol. 14(2), pages 253-272, December.
    3. Mariola Zalewska, 2011. "Effectiveness of health care in the OECD and EU countries with the innovation factor taken into account (Efektywnosc w ochronie zdrowia w krajach OECD i UE z uwzglednieniem czynnika innowacyjnosci)," Problemy Zarzadzania, University of Warsaw, Faculty of Management, vol. 9(33), pages 42-61.
    4. Markiewicz, Katarzyna & van Til, Janine A. & Steuten, Lotte M.G. & IJzerman, Maarten J., 2016. "Commercial viability of medical devices using Headroom and return on investment calculation," Technological Forecasting and Social Change, Elsevier, vol. 112(C), pages 338-346.
    5. Vogler, Sabine & Zimmermann, Nina & de Joncheere, Kees, 2016. "Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015," Health Policy, Elsevier, vol. 120(12), pages 1363-1377.
    6. W. Dominika Wranik & Liesl Gambold & Natasha Hanson & Adrian Levy, 2017. "The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation?," International Journal of Health Planning and Management, Wiley Blackwell, vol. 32(2), pages 232-260, April.
    7. Shavit, Oren, 2009. "Utilization of health technologies--Do not look where there is a light; shine your light where there is a need to look!: Relating national health goals with resource allocation decision-making; illust," Health Policy, Elsevier, vol. 92(2-3), pages 268-275, October.
    8. Gabriele Palozzi & Sandro Brunelli & Camilla Falivena, 2018. "Higher Sustainability and Lower Opportunistic Behaviour in Healthcare: A New Framework for Performing Hospital-Based Health Technology Assessment," Sustainability, MDPI, vol. 10(10), pages 1-19, October.

Articles

  1. Mareike Schad & Jürgen John, 2012. "Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(2), pages 127-144, April.

    Cited by:

    1. Akbulut, Hale & Seçilmiş, Erdem, 2019. "Estimation of a social discount rate for Turkey," Socio-Economic Planning Sciences, Elsevier, vol. 67(C), pages 78-85.
    2. Becker, Christian & Holle, Rolf & Stollenwerk, Björn, 2015. "The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention," Health Policy, Elsevier, vol. 119(6), pages 778-786.
    3. Johnson, Daniel & Geisendorf, Sylvie, 2019. "Are Neighborhood-level SUDS Worth it? An Assessment of the Economic Value of Sustainable Urban Drainage System Scenarios Using Cost-Benefit Analyses," Ecological Economics, Elsevier, vol. 158(C), pages 194-205.

  2. Breitfelder, Ariane & Wenig, Christina M. & Wolfenstetter, Silke B. & Rzehak, Peter & Menn, Petra & John, Jürgen & Leidl, Reiner & Bauer, Carl Peter & Koletzko, Sibylle & Röder, Stefan & Herbarth, Olf, 2011. "Relative weight-related costs of healthcare use by children--Results from the two German birth cohorts, GINI-plus and LISA-plus," Economics & Human Biology, Elsevier, vol. 9(3), pages 302-315, July.

    Cited by:

    1. Buchmueller, Thomas C. & Johar, Meliyanni, 2015. "Obesity and health expenditures: Evidence from Australia," Economics & Human Biology, Elsevier, vol. 17(C), pages 42-58.
    2. Kinge, Jonas Minet & Morris, Stephen, 2014. "Association between obesity and prescribed medication use in England," Economics & Human Biology, Elsevier, vol. 15(C), pages 47-55.
    3. Rahkovsky, Ilya & Gregory, Christian A., 2013. "Food prices and blood cholesterol," Economics & Human Biology, Elsevier, vol. 11(1), pages 95-107.
    4. Batscheider, Ariane & Rzehak, Peter & Teuner, Christina M. & Wolfenstetter, Silke B. & Leidl, Reiner & von Berg, Andrea & Berdel, Dietrich & Hoffmann, Barbara & Heinrich, Joachim, 2014. "Development of BMI values of German children and their healthcare costs," Economics & Human Biology, Elsevier, vol. 12(C), pages 56-66.
    5. Mora, Toni & Llargués, Esteve & Recasens, Assumpta, 2015. "Does health education affect BMI? Evidence from a school-based randomised-control trial," Economics & Human Biology, Elsevier, vol. 17(C), pages 190-201.
    6. Black, Nicole & Hughes, Robert & Jones, Andrew M., 2018. "The health care costs of childhood obesity in Australia: An instrumental variables approach," Economics & Human Biology, Elsevier, vol. 31(C), pages 1-13.
    7. Fenske Nora & Fahrmeir Ludwig & Hothorn Torsten & Rzehak Peter & Höhle Michael, 2013. "Boosting Structured Additive Quantile Regression for Longitudinal Childhood Obesity Data," The International Journal of Biostatistics, De Gruyter, vol. 9(1), pages 1-18, July.

  3. Hartz, Susanne & John, Jürgen, 2009. "Public health policy decisions on medical innovations: What role can early economic evaluation play?," Health Policy, Elsevier, vol. 89(2), pages 184-192, February.
    See citations under working paper version above.
  4. Thomas Lengerke & Christian Janssen & Jürgen John, 2007. "Sense of coherence, health locus of control, and quality of life in obese adults: physical limitations and psychological normalcies," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 52(1), pages 16-26, February.

    Cited by:

    1. Karl A Forsberg & Tommy Björkman & Per O Sandman & Mikael Sandlund, 2010. "Influence of a lifestyle intervention among persons with a psychiatric disability: a cluster randomised controlled trail on symptoms, quality of life and sense of coherence," Journal of Clinical Nursing, John Wiley & Sons, vol. 19(11‐12), pages 1519-1528, June.

  5. Olaf Winkelhake & Jürgen John, 1998. "Risk equalization, competition and choice in Germany: A reply to Wysong and Abel," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 43(1), pages 3-4, January.

    Cited by:

    1. Konstantin Beck, 1998. "Competition under a regime of imperfect risk adjustment: The Swiss experience," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 43(1), pages 7-8, January.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

Featured entries

This author is featured on the following reading lists, publication compilations, Wikipedia, or ReplicationWiki entries:
  1. Programme \"Technology, Innovation and Society\" at Helmholtz Association (Germany)

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 1 paper announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (1) 2007-12-08

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Juergen John should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.